Key facts
- This page summarizes Kevin Pollack's Form 4 filing for PRESSURE BIOSCIENCES INC.
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 28 Mar 2024, 14:07.
Kevin Pollack - 27 Mar 2024 Form 4 Insider Report for PRESSURE BIOSCIENCES INC
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 27 Mar 2024
- Net transaction value
- +$466
- SEC form
- 4
- Accepted by SEC
- 28 Mar 2024, 14:07:26 UTC
- Prior SEC filing
- 08 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kevin Pollack
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kevin Pollack filed Form 4 for PRESSURE BIOSCIENCES INC on 28 Mar 2024.
Change
- Previous filing in this sequence was filed on 08 Dec 2023.
- Current net transaction value: +$466.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PBIO
transaction
Common Stock
Other
- Transaction value
- $466
- Shares
- +2,914
- Change %
- +8.6%
- Price
- $0.1600
- Shares after
- 36,787
- Date
- 27 Mar 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Interest on convertible preferred stock paid in shares of common stock.